VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 139 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $34,000 | -12.8% | 2,085 | -28.9% | 0.00% | – |
| Q3 2019 | $39,000 | -25.0% | 2,931 | -21.0% | 0.00% | – |
| Q2 2019 | $52,000 | -23.5% | 3,712 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $68,000 | -11.7% | 3,712 | +27.3% | 0.00% | 0.0% |
| Q4 2018 | $77,000 | +92.5% | 2,916 | +66.2% | 0.00% | – |
| Q3 2018 | $40,000 | +21.2% | 1,755 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | +10.0% | 1,755 | 0.0% | 0.00% | – |
| Q1 2018 | $30,000 | +11.1% | 1,755 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | -12.9% | 1,755 | 0.0% | 0.00% | – |
| Q3 2017 | $31,000 | +6.9% | 1,755 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $29,000 | +16.0% | 1,755 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $25,000 | – | 1,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |